Document is current
Any future updates will be listed below
-
Authors
Rosenbusch, Marie-Luise
Below, Maike
Klimke, Kerstin
Bätzing, Jörg
Pieper, Stefan
Vockeroth, Clarissa
Falk, Volkmar
Kurz, Stephan
-
Funding
Funding for this research was provided by:
Associations of Statutory Health Insurance Physicians and National Association of Statutory Health Insurance Physicians
- License Information
-
More Information
Article History
Received: 13 February 2024
Accepted: 24 August 2025
First Online: 23 September 2025
Declarations
:
: The secondary data analysis is based on the pseudonymized drug prescription data according to § 300 SGB V as well as the diagnostic data of outpatients according to § 295 SGB V. Since the processing of these data takes place within the framework of the tasks of the Associations of Statutory Health Insurance Physicians in Germany according to the German Social Security Code, Book V (here in particular 73 (8) SGB V) on behalf of the participating Associations of Statutory Health Insurance Physicians according to § 80 SGB X, the data can be processed without a declaration of consent. In principle, no ethical approval is required for secondary data analyses [].
: Not applicable.
: The authors declare no competing interests.
